Sophia Genetics partnering with Agilent Technologies to offer cancer analysis solution

By The Science Advisory Board staff writers

March 15, 2023 -- Healthcare software firm Sophia Genetics said on Tuesday that it is partnering with Agilent Technologies to offer a comprehensive solution for cancer analysis.

Through the partnership, the Sophia DDM Platform will be integrated with Agilent's research-use-only SureSelect Cancer Comprehensive Genomic Profiling (CGP) Assay Kit.

The integration will enable clinical researchers to accurately identify multiple biomarkers, lowering the risk of missing important information in cancer samples, Sophia Genetics said, adding that the partnership brings together the companies' strengths in analytics and next-generation sequencing (NGS) assay development to facilitate novel approaches to cancer research.

Sophia Genetics added that it is tailoring its analytics to work with Agilent's target enrichment technology so that users have access to an advanced solution that allows multiple tumor markers to be detected.

With the Sophia DDM Platform, users will have an integrated solution with reporting tools that go beyond simple readouts and are aligned with the information and input from the latest guidelines and clinical trials reflecting relevant biomarkers, Sophia Genetics added.

Copyright © 2023

Create an Account

Already have an account? Sign in Here

To access all ScienceBoard content create a free account now:

Email Address:  

First Name:

Last Name:

I have read and agree to the privacy policy and terms of service and wish to opt-in for

Email Preferences

Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.